The FDA has approved Bayer's autoinjector BETACONNECT as a means of administrating BETASERON for treating relapsing-remitting multiple sclerosis, offering another treatment option for the disease.
FDA Issues Approval For Bayer Autoinjector For Multiple Sclerosis Therapy
Tech Times - 26 Sep 2015 15:59
The FDA has approved Bayer's autoinjector BETACONNECT as a means of administrating BETASERON for treating relapsing-remitting multiple sclerosis, offering another treatment option for the disease.
Share this Article
Recommended